A recent study looked at 679 patients across 21 global sites in the U.S., Canada, and Hong Kong, Johnson & Johnson MedTech said.
A recent study looked at 679 patients across 21 global sites in the U.S., Canada, and Hong Kong, Johnson & Johnson MedTech said.